Cardiac magnetic resonance imaging and management of dilated cardiomyopathy in a Duchenne muscular dystrophy manifesting carrier

J Neurol. 2009 Feb;256(2):283-4. doi: 10.1007/s00415-009-0055-7. Epub 2009 Feb 27.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Biomarkers / analysis
  • Biomarkers / blood
  • Carbazoles / therapeutic use
  • Cardiomyopathy, Dilated / genetics*
  • Cardiomyopathy, Dilated / pathology*
  • Cardiomyopathy, Dilated / therapy
  • Carvedilol
  • Child
  • Creatine Kinase / analysis
  • Creatine Kinase / blood
  • DNA Mutational Analysis
  • Disease Progression
  • Dystrophin / deficiency
  • Dystrophin / genetics
  • Echocardiography
  • Exercise
  • Female
  • Heart Conduction System / physiopathology
  • Heart Conduction System / surgery
  • Heart Ventricles / diagnostic imaging
  • Heart Ventricles / pathology*
  • Heart Ventricles / physiopathology
  • Heterozygote
  • Humans
  • Muscle, Skeletal / metabolism
  • Muscle, Skeletal / pathology
  • Muscle, Skeletal / physiopathology
  • Muscular Dystrophy, Duchenne / complications*
  • Muscular Dystrophy, Duchenne / genetics*
  • Mutation / genetics
  • Myocardium / metabolism
  • Myocardium / pathology
  • Propanolamines / therapeutic use
  • Spironolactone / therapeutic use
  • Tachycardia / etiology
  • Tachycardia / physiopathology
  • Tachycardia / surgery
  • Treatment Outcome

Substances

  • Biomarkers
  • Carbazoles
  • Dystrophin
  • Propanolamines
  • Carvedilol
  • Spironolactone
  • Creatine Kinase